WebFeb 10, 2024 · Biogen reported sales of $3.84B in 2024, and GlobalData forecasts that Tecfidera will generate sales of $1.12B in 2026 due to generic competition. The decline … WebJan 30, 2024 · While Pfizer is expected to see the fastest decline in neurology sales, as exemplified by its negative CAGR of 13.3% over 2024-25, resulting in the company …
Biogen Competitors Comparably
WebFeb 25, 2024 · Novartis has asked U.S. and European regulators to review its biosimilar of Biogen’s multiple sclerosis drug Tysabri, the company said Monday. If approved, the copycat version Tysabri could potentially launch as soon as next year. Tysabri has become Biogen’s biggest-selling drug since generic competitors to its MS pill Tecfidera entered … WebJan 28, 2024 · The entry in the U.S. of generic competitors to Biogen's top-selling multiple sclerosis treatment Tecfidera, meanwhile, has dragged heavily on the company's revenue. In December, Biogen said it would cut costs by $500 million. simon knoll platz münchen
Biogen Idec: A True Competitor On Sustainability Metrics
WebCompetitors for Biogen Inc (BIIB): view how companies in the same sector perform against each other. Competitors for Biogen Inc (BIIB): view how companies in the same sector perform against each other. ... Top Stories Aerospace Agriculture Business Services Construction Consumer Products Corporate Economic News Energy & Oil Finance and … WebBiogen Competitors. Biogen competitors include Emergent Biosolutions, Johnson & Johnson, Pfizer, Amgen and Gilead Sciences. Biogen ranks 1st in Product Quality Score on Comparably vs its competitors. See below … WebBiogen top competitors include: Tamar Energy Ltd, Yorwaste Ltd, Biffa PLC, Warrens Group Ltd What companies has Biogen acquired? Biogen has acquired the companies: … simon knowler